BEONE MEDICINES LTD. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $63.88M, a 307.81% increase year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $19.52M, a 12.07% increase year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $4.49M, a 21.67% increase year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-03-31 was $15.66M, a 45.34% decline year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $46.96M, a 49.37% decline from fiscal 2021.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $92.76M, a 0.36% decline from fiscal 2020.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2020 was $93.10M, a 98.07% increase from fiscal 2019.
- BEONE MEDICINES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2019 was $47.00M.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2025-03-31 | $63.88M 10-Q · filed 2025-05-07 | |
| 2024-09-30 | $19.52M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $4.49M 10-Q · filed 2024-11-12 | |
| 2024-03-31 | $15.66M 10-Q · filed 2025-05-07 | |
| 2023-09-30 | $17.42M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $3.69M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $28.66M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $46.96M 10-K · filed 2023-02-27 | |
| 2022-09-30 | $16.70M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $7.09M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $11.88M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $92.76M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $46.59M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $9.85M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $25.75M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $93.10M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $47.63M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $16.57M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $11.63M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $47.00M 10-K · filed 2022-02-28 |